{"url":"https://lda.senate.gov/api/v1/filings/be5ec638-e1c1-4ebe-81da-b23fe2425f2f/","filing_uuid":"be5ec638-e1c1-4ebe-81da-b23fe2425f2f","filing_type":"3A","filing_type_display":"3rd Quarter - Amendment","filing_year":2014,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/be5ec638-e1c1-4ebe-81da-b23fe2425f2f/print/","filing_document_content_type":"text/html","income":"15000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"John Coster","dt_posted":"2014-10-05T10:02:22.187000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"2716 Franklin Ct","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Alexandria","registrant_state":"VA","registrant_zip":"22302","registrant":{"id":401103305,"url":"https://lda.senate.gov/api/v1/registrants/401103305/","house_registrant_id":null,"name":"MR. JOHN COSTER","description":"Pharmaceutical issues lobbying, regulatory and policy","address_1":"2716 Franklin Ct","address_2":null,"address_3":null,"address_4":null,"city":"Alexandria","state":"VA","state_display":"Virginia","zip":"22302","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JOHN COSTER","contact_telephone":"+1 703-888-0859","dt_updated":"2022-04-06T16:06:26.074738-04:00"},"client":{"id":198511,"url":"https://lda.senate.gov/api/v1/clients/198511/","client_id":12,"name":"AMERISOURCE BERGEN","general_description":"pharmaceutical and health care product distribution","client_government_entity":false,"client_self_select":null,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2014-06-02"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60547,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"COSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"pharmaceutical and health care product distribution issues, Medicare Part B and D issues, Medicaid pharmacy issues, HR 800, S. 806, HR 4709, Ensuring Patient Access and Effective Drug Enforcement Act of 2014.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":60547,"prefix":null,"prefix_display":null,"first_name":"JOHN","nickname":null,"middle_name":null,"last_name":"COSTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}